Literature DB >> 8498505

Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model.

A Caumo1, C Cobelli.   

Abstract

A method for the estimation of hepatic glucose production during a labeled intravenous glucose tolerance test (IVGTT) is proposed. Stable-label IVGTT data in normal subjects have been considered. The method is based on deconvolution and uses a new two-compartment minimal model of glucose kinetics to describe the time-varying impulse response of the glucose system. A new model of glucose kinetics was needed because the available single-compartment minimal model, specifically developed to interpret labeled IVGTT data, provided a nonphysiological pattern of hepatic glucose production. The new minimal model has two novel features: glucose kinetics are described by a two-compartment structure, and insulin exerts its action on the irreversible loss of the slowly exchanging glucose pool. The deconvolution scheme used to reconstruct hepatic glucose production is described in detail both in terms of computational aspects and reliability. Confidence limits of the reconstructed hepatic glucose production in each individual are derived by taking into account both the measurement error of the data and the uncertainty associated with the description of the impulse response. Physiological plausibility of the time course of hepatic glucose production provided by this new method is discussed. The ability of the new model to reconstruct hepatic glucose production considerably enriches the kinetic portrait of glucose metabolism that can be obtained from the minimal-model analysis of labeled IVGTT data.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8498505     DOI: 10.1152/ajpendo.1993.264.5.E829

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Is the minimal model too minimal?

Authors:  A Caumo; P Vicini; C Cobelli
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

2.  Design and clinical pilot testing of the model-based dynamic insulin sensitivity and secretion test (DISST).

Authors:  Thomas F Lotz; J Geoffrey Chase; Kirsten A McAuley; Geoffrey M Shaw; Paul D Docherty; Juliet E Berkeley; Sheila M Williams; Christopher E Hann; Jim I Mann
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

3.  Diabetes: Models, Signals, and Control.

Authors:  Claudio Cobelli; Chiara Dalla Man; Giovanni Sparacino; Lalo Magni; Giuseppe De Nicolao; Boris P Kovatchev
Journal:  IEEE Rev Biomed Eng       Date:  2009-01-01

4.  Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components.

Authors:  M Ader; T C Ni; R N Bergman
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

5.  A convenient LC-MS method for assessment of glucose kinetics in vivo with D-[13C6]glucose as a tracer.

Authors:  Haoyue Zhang; Robert D Stevens; Sarah P Young; Richard Surwit; Anastasia Georgiades; Raymond Boston; David S Millington
Journal:  Clin Chem       Date:  2009-01-30       Impact factor: 8.327

6.  Analysis of PK/PD risk factors for development of type 2 diabetes in high risk population using Bayesian analysis of glucose-insulin kinetics.

Authors:  Chih-Wei Lin; Peter Veng-Pedersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-09-16       Impact factor: 2.745

7.  Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolism.

Authors:  Matthias König; Sascha Bulik; Hermann-Georg Holzhütter
Journal:  PLoS Comput Biol       Date:  2012-06-21       Impact factor: 4.475

8.  A computational model of the human glucose-insulin regulatory system.

Authors:  Keh-Dong Shiang; Fouad Kandeel
Journal:  J Biomed Res       Date:  2010-09

9.  Insulin sensitivity assessed by stable isotopes with oral glucose administration: validation with euglycaemic clamp.

Authors:  Leslie Bluck; Rachel Williams; Sarah Jackson; Burak Salgin; Carlo Acerini; David Dunger
Journal:  ISRN Endocrinol       Date:  2013-11-03

10.  Weight-HbA1c-insulin-glucose model for describing disease progression of type 2 diabetes.

Authors:  S Choy; M C Kjellsson; M O Karlsson; W de Winter
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.